Bph Vs Cancer Screening Talk

A person with a prostate may present with weak stream, hesitancy, nocturia, urgency, or incomplete emptying and ask, “Is this BPH, or could it be cancer?” Those are two related clinical concerns, but they are not the same diagnostic question. Lower urinary tract symptoms (LUTS) usually prompt assessment because they are bothersome or impair function. Prostate cancer screening, by contrast, is a preventive decision made before cancer is suspected and only after discussing the possible benefits, harms, and consequences of testing. The first task is therefore to separate three decisions: how severe and bothersome the urinary symptoms are, whether another condition is causing them, and whether this person wants an informed prostate-cancer screening pathway. BPH does not cause prostate cancer. Symptom severity does not reliably predict cancer, and a PSA result does not by itself diagnose or exclude it. A safe conversation does not turn every urinary complaint into automatic PSA testing. It establishes the purpose of the test, assesses life expectancy and risk, explains what an abnormal result could lead to, and documents the person's preference.